Cargando…

Comprehensive Physiological Modeling Provides Novel Insights Into Heart Failure With Preserved Ejection Fraction Physiology

BACKGROUND: Although a rapid rise in left atrial pressure during exertion is considered pathognomonic of heart failure with preserved ejection fraction (HFpEF), the fundamental circulatory determinants of this response are not clear, impacting upon the development of more effective therapies. We aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaye, David M., Wolsk, Emil, Nanayakkara, Shane, Mariani, Justin, Hassager, Christian, Gustafsson, Finn, Moller, Jacob E., Sunagawa, Kenji, Burkhoff, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649144/ https://www.ncbi.nlm.nih.gov/pubmed/34569288 http://dx.doi.org/10.1161/JAHA.121.021584

Ejemplares similares

Identification of physiologic treatment targets with favourable haemodynamic consequences in heart failure with preserved ejection fraction
por: Kaye, David M., et al.
Publicado: (2020)

The effect of parity on exercise physiology in women with heart failure with preserved ejection fraction
por: Beale, Anna L., et al.
Publicado: (2020)

Management of heart failure with preserved ejection fraction
por: Gard, Emma, et al.
Publicado: (2020)

Interatrial Shunt Device for Heart Failure With Preserved Ejection Fraction
por: Kaye, David M., et al.
Publicado: (2019)

Hospitalisation in Patients With Heart Failure With Preserved Ejection Fraction
por: Nanayakkara, Shane, et al.
Publicado: (2018)

Device therapy with interatrial shunt devices for heart failure with preserved ejection fraction
por: Nanayakkara, Shane, et al.
Publicado: (2022)

Hemodynamic Profile of Patients With Heart Failure and Preserved Ejection Fraction Vary by Age
por: Nanayakkara, Shane, et al.
Publicado: (2017)

Resting and exercise haemodynamic characteristics of patients with advanced heart failure and preserved ejection fraction
por: Deis, T., et al.
Publicado: (2021)

Extended‐Release Oral Milrinone for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Nanayakkara, Shane, et al.
Publicado: (2020)

The Gut Microbiome of Heart Failure With Preserved Ejection Fraction
por: Beale, Anna L., et al.
Publicado: (2021)

Physiological stimulation in preserved ejection fraction: A randomized trial
por: Rodriguez Queralto, O, et al.
Publicado: (2023)

Impact of Sex on Ventricular‐Vascular Stiffness and Long‐Term Outcomes in Heart Failure With Preserved Ejection Fraction: TOPCAT Trial Substudy
por: Beale, Anna L., et al.
Publicado: (2019)

Characteristics and long‐term prognosis of patients with heart failure and mid‐range ejection fraction compared with reduced and preserved ejection fraction: a systematic review and meta‐analysis
por: Lauritsen, Josephine, et al.
Publicado: (2018)

Device-Based Solutions to Improve Cardiac Physiology and Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: Rosalia, Luca, et al.
Publicado: (2021)

Impaired Myocardial Oxygen Availability Contributes to Abnormal Exercise Hemodynamics in Heart Failure With Preserved Ejection Fraction
por: van Empel, Vanessa P. M., et al.
Publicado: (2014)

Mild aortic valve disease and the diastolic pressure–volume relationship in heart failure with preserved ejection fraction
por: Verbrugge, Frederik H, et al.
Publicado: (2021)

Insights from physiology applied to interpretation of supranormal ejection fraction in women
por: Kerkhof, Peter L M, et al.
Publicado: (2020)

Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
por: Kanagala, Prathap, et al.
Publicado: (2019)

Heterogeneous responses of systolic and diastolic left ventricular function to exercise in patients with heart failure and preserved ejection fraction
por: Kasner, Mario, et al.
Publicado: (2015)

Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction
por: Kaye, David M., et al.
Publicado: (2018)

Heart failure with preserved ejection fraction
por: Rigolli, Marzia, et al.
Publicado: (2013)

Heart failure with preserved ejection fraction
por: ElGuindy, Ahmed, et al.
Publicado: (2012)

Impact of Interatrial Shunts on Invasive Hemodynamics and Exercise Tolerance in Patients With Heart Failure
por: Griffin, Jan M., et al.
Publicado: (2020)

Empagliflozin in heart failure patients with reduced ejection fraction: a randomized clinical trial (Empire HF)
por: Jensen, Jesper, et al.
Publicado: (2019)

Biomarkers in heart failure with preserved ejection fraction
por: Meijers, W. C., et al.
Publicado: (2016)

Managing heart failure with preserved ejection fraction
por: Davidson, Alexander, et al.
Publicado: (2020)

Biomarkers in Heart Failure with Preserved Ejection Fraction
por: Bayes-Genis, Antoni, et al.
Publicado: (2022)

Comorbidities in heart failure with preserved ejection fraction
por: Deichl, Andrea, et al.
Publicado: (2022)

Pressure–flow responses to exercise in aortic stenosis, mitral regurgitation and diastolic dysfunction
por: Andersen, Mads J, et al.
Publicado: (2022)

Rationale and design of SAVI-AoS: A physiologic study of patients with symptomatic moderate aortic valve stenosis and preserved left ventricular ejection fraction
por: Eerdekens, Rob, et al.
Publicado: (2022)

Contemporary Drug Treatment of Advanced Heart Failure with Reduced Ejection Fraction
por: Vishram-Nielsen, Julie K. K., et al.
Publicado: (2022)

One-Year Outcomes After Transcatheter Insertion of an Interatrial Shunt Device for the Management of Heart Failure With Preserved Ejection Fraction
por: Kaye, David M., et al.
Publicado: (2016)

Uric acid in advanced heart failure: relation to central haemodynamics and outcome
por: Deis, Tania, et al.
Publicado: (2022)

Iron deficiency in heart failure with preserved ejection fraction: a systematic review and meta-analysis
por: Beale, Anna L, et al.
Publicado: (2019)

Metabolomic Fingerprint of Heart Failure with Preserved Ejection Fraction
por: Zordoky, Beshay N., et al.
Publicado: (2015)

Clinical Phenotypes in Heart Failure With Preserved Ejection Fraction
por: Samson, Rohan, et al.
Publicado: (2016)

Animal models of heart failure with preserved ejection fraction
por: Conceição, G., et al.
Publicado: (2016)

Cell Therapy for Heart Failure With Preserved Ejection Fraction
por: Borlaug, Barry A., et al.
Publicado: (2016)

Modelling the complexity of heart failure with preserved ejection fraction
por: O’Gallagher, Kevin, et al.
Publicado: (2018)

Microvascular Rarefaction and Heart Failure With Preserved Ejection Fraction
por: Zeng, Heng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_q33kh6cr9928u2e5tsop10f4o3